FC
RCEL icon

FORA Capital’s Avita Medical RCEL Stock Holding History

FORA Capital’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-959
Closed -$20K – 753
2021
Q2 		$20K Buy
+959
New +$18.9K ﹤0.01% 828

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FORA Capital's RCEL Position: Q3 2021 in Review

FORA Capital sold out of Avita Medical (RCEL) in Q3 2021, closing a stake of 959 shares — an estimated $20K sold.

FORA Capital first reported a position in RCEL in Q2 2021 and held it in 1 quarter. The position peaked at $20K in Q2 2021. 69 funds tracked by Wall St. Rank hold RCEL as of Q3 2021.

  • FORA Capital reported no remaining Avita Medical position as of Q3 2021 after selling out during the quarter.
  • FORA Capital sold 959 Avita Medical shares in Q3 2021, an estimated $20K.
  • FORA Capital first reported a position in Avita Medical in Q2 2021 and held it in 1 quarter.
  • FORA Capital's Avita Medical position peaked at $20K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Avita Medical as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.